Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

SELL
$73.85 - $86.14 $5,169 - $6,029
-70 Reduced 0.55%
12,596 $991,000
Q3 2022

Oct 14, 2022

BUY
$63.3 - $78.66 $67,794 - $84,244
1,071 Added 9.24%
12,666 $938,000
Q2 2022

Jul 12, 2022

SELL
$49.27 - $66.08 $985 - $1,321
-20 Reduced 0.17%
11,595 $756,000
Q1 2022

Apr 07, 2022

SELL
$43.77 - $63.22 $9,716 - $14,034
-222 Reduced 1.88%
11,615 $734,000
Q4 2021

Jan 13, 2022

BUY
$49.55 - $74.59 $37,459 - $56,390
756 Added 6.82%
11,837 $628,000
Q3 2021

Jan 13, 2022

BUY
$57.6 - $70.59 $460 - $564
8 Added 0.07%
11,081 $782,000
Q2 2021

Jul 20, 2021

BUY
$51.81 - $118.56 $573,692 - $1.31 Million
11,073 New
11,073 $738,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.